• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常受试者和髓样癌患者血浆及尿液中降钙素形式的鉴定与特性分析。

Identification and characterization of calcitonin forms in plasma and urine of normal subjects and medullary carcinoma patients.

作者信息

Tobler P H, Tschopp F A, Dambacher M A, Born W, Fischer J A

出版信息

J Clin Endocrinol Metab. 1983 Oct;57(4):749-54. doi: 10.1210/jcem-57-4-749.

DOI:10.1210/jcem-57-4-749
PMID:6885964
Abstract

Different immunoreactive calcitonin (CT) forms were identified by a reversed phase high performance liquid chromatography gradient system in plasma and urine of normal subjects. The separated CT components were characterized by chemical and enzymatic methods and found to be identical in normal subjects and medullary thyroid carcinoma patients. Of seven major CT forms we identified monomeric human CT-(1-32), its sulfoxide form, and dimeric CT in plasma. The monomeric, but not the dimeric form, was also detected in urine. A predominant CT component in plasma with a molecular weight of about 12,000 may correspond to a biosynthetic precursor of the hormone.

摘要

通过反相高效液相色谱梯度系统在正常受试者的血浆和尿液中鉴定出不同的免疫反应性降钙素(CT)形式。分离出的CT成分通过化学和酶学方法进行表征,发现其在正常受试者和甲状腺髓样癌患者中是相同的。在我们鉴定出的七种主要CT形式中,血浆中有单体人CT-(1-32)、其亚砜形式和二聚体CT。尿液中也检测到了单体形式,但未检测到二聚体形式。血浆中一种主要的分子量约为12,000的CT成分可能对应于该激素的生物合成前体。

相似文献

1
Identification and characterization of calcitonin forms in plasma and urine of normal subjects and medullary carcinoma patients.正常受试者和髓样癌患者血浆及尿液中降钙素形式的鉴定与特性分析。
J Clin Endocrinol Metab. 1983 Oct;57(4):749-54. doi: 10.1210/jcem-57-4-749.
2
A new bioactive form of human calcitonin.
Cancer Res. 1983 Aug;43(8):3793-9.
3
Immunochemical heterogeneity of calcitonin in plasma of patients with medullary thryoid carcinoma.甲状腺髓样癌患者血浆中降钙素的免疫化学异质性。
J Clin Invest. 1975 May;55(5):1111-8. doi: 10.1172/JCI108012.
4
Characterization of the major forms of human calcitonin in tissue and serum.人体组织和血清中主要形式的降钙素的特征分析。
J Clin Endocrinol Metab. 1981 Jun;52(6):1090-8. doi: 10.1210/jcem-52-6-1090.
5
Heterogeneity of immunoreactive calcitonin in extracts of medullary thyroid carcinoma.甲状腺髓样癌提取物中免疫反应性降钙素的异质性。
Miner Electrolyte Metab. 1982 Jun;7(6):292-7.
6
Heterogeneity of plasma and urinary immunoreactive calcitonin in patients with medullary carcinoma of the thyroid.甲状腺髓样癌患者血浆和尿免疫反应性降钙素的异质性。
Endocrinol Jpn. 1981 Oct;28(5):583-94. doi: 10.1507/endocrj1954.28.583.
7
Heterogeneity of immunoreactive calcitonin in extracts of normal human thyroid.正常人甲状腺提取物中免疫反应性降钙素的异质性
Horm Metab Res. 1981 Aug;13(8):460-3. doi: 10.1055/s-2007-1019301.
8
Characterization of the immunochemical forms of calcitonin released by a medullary thyroid carcinoma in tissue culture.甲状腺髓样癌在组织培养中释放的降钙素免疫化学形式的特征分析。
J Clin Invest. 1978 Feb;61(2):449-58. doi: 10.1172/JCI108956.
9
Calcitonin in plasma and cerebrospinal fluid from normal subjects and patients with medullary thyroid carcinoma: possible restriction of calcitonin by the blood-brain barrier.正常受试者和甲状腺髓样癌患者血浆及脑脊液中的降钙素:血脑屏障对降钙素可能存在的限制作用
J Clin Endocrinol Metab. 1982 Sep;55(3):594-6. doi: 10.1210/jcem-55-3-594.
10
Radioimmunoassay of human calcitonin in serum and tissue from healthy individuals and patients with medullary carcinoma of the thyroid gland.健康个体及甲状腺髓样癌患者血清和组织中人类降钙素的放射免疫测定。
Scand J Clin Lab Invest. 1976 Jul;36(4):323-9.

引用本文的文献

1
Calcitonin as Biomarker for the Medullary Thyroid Carcinoma.降钙素作为甲状腺髓样癌的生物标志物。
Recent Results Cancer Res. 2025;223:155-182. doi: 10.1007/978-3-031-80396-3_6.
2
Circulating Biomarkers of Thyroid Cancer: An Appraisal.甲状腺癌的循环生物标志物:评估
J Clin Med. 2025 Feb 26;14(5):1582. doi: 10.3390/jcm14051582.
3
Calcitonin: current concepts and differential diagnosis.降钙素:当前概念与鉴别诊断
Ther Adv Endocrinol Metab. 2022 May 21;13:20420188221099344. doi: 10.1177/20420188221099344. eCollection 2022.
4
Oxidation of therapeutic proteins and peptides: structural and biological consequences.治疗性蛋白质和肽的氧化:结构和生物学后果
Pharm Res. 2014 Mar;31(3):541-53. doi: 10.1007/s11095-013-1199-9. Epub 2013 Sep 25.
5
Bacterial peptide methionine sulphoxide reductase: co-induction with glutathione S-transferase during chemical stress conditions.细菌肽甲硫氨酸亚砜还原酶:在化学应激条件下与谷胱甘肽S-转移酶共同诱导。
Biochem J. 2001 Dec 15;360(Pt 3):675-81. doi: 10.1042/0264-6021:3600675.
6
Escherichia coli peptide methionine sulfoxide reductase gene: regulation of expression and role in protecting against oxidative damage.大肠杆菌肽甲硫氨酸亚砜还原酶基因:表达调控及在抵御氧化损伤中的作用
J Bacteriol. 1995 Feb;177(3):502-7. doi: 10.1128/jb.177.3.502-507.1995.
7
Pathophysiological study of diarrhoea in a patient with medullary thyroid carcinoma. Evidence against a secretory mechanism and for the role of shortened colonic transit time.甲状腺髓样癌患者腹泻的病理生理学研究。反对分泌机制及支持结肠转运时间缩短作用的证据
Gut. 1988 Apr;29(4):537-43. doi: 10.1136/gut.29.4.537.
8
Effect of calcitonin deficiency on bone density and bone turnover in totally thyroidectomized patients.
J Endocrinol Invest. 1991 Dec;14(11):935-42. doi: 10.1007/BF03347119.